Cargando…
Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate
Galactosaemia has been included in various newborn screening programs since 1963. Several methods are used for screening; however, the predominant methods used today are based on the determination of either galactose-1-phosphate uridyltransferase (GALT) activity or the concentration of total galacto...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510209/ https://www.ncbi.nlm.nih.gov/pubmed/33072978 http://dx.doi.org/10.3390/ijns5020019 |
_version_ | 1783585740422119424 |
---|---|
author | Cohen, Arieh S. Baurek, Marta Lund, Allan M. Dunø, Morten Hougaard, David M. |
author_facet | Cohen, Arieh S. Baurek, Marta Lund, Allan M. Dunø, Morten Hougaard, David M. |
author_sort | Cohen, Arieh S. |
collection | PubMed |
description | Galactosaemia has been included in various newborn screening programs since 1963. Several methods are used for screening; however, the predominant methods used today are based on the determination of either galactose-1-phosphate uridyltransferase (GALT) activity or the concentration of total galactose. These methods cannot be multiplexed and therefore require one full punch per sample. Since the introduction of mass spectrometry in newborn screening, many diseases have been included in newborn screening programs. Here, we present a method for including classical galactosaemia in an expanded newborn screening panel based on the specific determination of galactose-1-phosphate by tandem mass spectrometry. The existing workflow only needs minor adjustments, and it can be run on the tandem mass spectrometers in routine use. Furthermore, compared to the currently used methods, this novel method has a superior screening performance, producing significantly fewer false positive results. We present data from 5500 routine newborn screening samples from the Danish Neonatal Screening Biobank. The cohort was enriched by including 14 confirmed galactosaemia positive samples and 10 samples positive for other metabolic disorders diagnosed through the Danish newborn screening program. All galactosaemia positive samples were identified by the method with no false positives. Furthermore, the screening performance for other metabolic disorders was unaffected. |
format | Online Article Text |
id | pubmed-7510209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75102092020-10-15 Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate Cohen, Arieh S. Baurek, Marta Lund, Allan M. Dunø, Morten Hougaard, David M. Int J Neonatal Screen Article Galactosaemia has been included in various newborn screening programs since 1963. Several methods are used for screening; however, the predominant methods used today are based on the determination of either galactose-1-phosphate uridyltransferase (GALT) activity or the concentration of total galactose. These methods cannot be multiplexed and therefore require one full punch per sample. Since the introduction of mass spectrometry in newborn screening, many diseases have been included in newborn screening programs. Here, we present a method for including classical galactosaemia in an expanded newborn screening panel based on the specific determination of galactose-1-phosphate by tandem mass spectrometry. The existing workflow only needs minor adjustments, and it can be run on the tandem mass spectrometers in routine use. Furthermore, compared to the currently used methods, this novel method has a superior screening performance, producing significantly fewer false positive results. We present data from 5500 routine newborn screening samples from the Danish Neonatal Screening Biobank. The cohort was enriched by including 14 confirmed galactosaemia positive samples and 10 samples positive for other metabolic disorders diagnosed through the Danish newborn screening program. All galactosaemia positive samples were identified by the method with no false positives. Furthermore, the screening performance for other metabolic disorders was unaffected. MDPI 2019-05-04 /pmc/articles/PMC7510209/ /pubmed/33072978 http://dx.doi.org/10.3390/ijns5020019 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cohen, Arieh S. Baurek, Marta Lund, Allan M. Dunø, Morten Hougaard, David M. Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate |
title | Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate |
title_full | Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate |
title_fullStr | Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate |
title_full_unstemmed | Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate |
title_short | Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate |
title_sort | including classical galactosaemia in the expanded newborn screening panel using tandem mass spectrometry for galactose-1-phosphate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510209/ https://www.ncbi.nlm.nih.gov/pubmed/33072978 http://dx.doi.org/10.3390/ijns5020019 |
work_keys_str_mv | AT cohenariehs includingclassicalgalactosaemiaintheexpandednewbornscreeningpanelusingtandemmassspectrometryforgalactose1phosphate AT baurekmarta includingclassicalgalactosaemiaintheexpandednewbornscreeningpanelusingtandemmassspectrometryforgalactose1phosphate AT lundallanm includingclassicalgalactosaemiaintheexpandednewbornscreeningpanelusingtandemmassspectrometryforgalactose1phosphate AT dunømorten includingclassicalgalactosaemiaintheexpandednewbornscreeningpanelusingtandemmassspectrometryforgalactose1phosphate AT hougaarddavidm includingclassicalgalactosaemiaintheexpandednewbornscreeningpanelusingtandemmassspectrometryforgalactose1phosphate |